SANUWAVE Health Inc
OTC:SNWV

Watchlist Manager
SANUWAVE Health Inc Logo
SANUWAVE Health Inc
OTC:SNWV
Watchlist
Price: 29.88 USD -8.61% Market Closed
Market Cap: 256.4m USD

SANUWAVE Health Inc
Total Other Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

SANUWAVE Health Inc
Total Other Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
SANUWAVE Health Inc
OTC:SNWV
Total Other Income
$5.4m
CAGR 3-Years
N/A
CAGR 5-Years
55%
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Total Other Income
$242m
CAGR 3-Years
N/A
CAGR 5-Years
117%
CAGR 10-Years
N/A
Stryker Corp
NYSE:SYK
Total Other Income
-$329m
CAGR 3-Years
-11%
CAGR 5-Years
1%
CAGR 10-Years
-13%
Abbott Laboratories
NYSE:ABT
Total Other Income
$602m
CAGR 3-Years
24%
CAGR 5-Years
N/A
CAGR 10-Years
8%
IDEXX Laboratories Inc
NASDAQ:IDXX
Total Other Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Intuitive Surgical Inc
NASDAQ:ISRG
Total Other Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

SANUWAVE Health Inc
Glance View

Market Cap
256.3m USD
Industry
Health Care

SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. The company is headquartered in Suwanee, Georgia and currently employs 43 full-time employees. The company went IPO on 2008-11-07. The firm's is focused on regenerative medicine utilizing noninvasive, acoustic shock waves to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body’s normal healing processes and regeneration. The firm's lead regenerative product in the United States is the dermaPACE device, used for treating diabetic foot ulcers. The company intends to apply its Pulsed Acoustic Cellular Expression (PACE) technology in wound healing, orthopedic, plastic/cosmetic and cardiac conditions.

SNWV Intrinsic Value
33.26 USD
Undervaluation 10%
Intrinsic Value
Price

See Also

What is SANUWAVE Health Inc's Total Other Income?
Total Other Income
5.4m USD

Based on the financial report for Sep 30, 2025, SANUWAVE Health Inc's Total Other Income amounts to 5.4m USD.

What is SANUWAVE Health Inc's Total Other Income growth rate?
Total Other Income CAGR 5Y
55%

Over the last year, the Total Other Income growth was 181%.

Back to Top